23andme news - Search News

23andMe to cut 40% of workforce, end therapeutics program

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the company announced Monday.

Hosted on MSN · 4h

23andMe to Cut Workforce by 40%, Discontinues Therapeutics Pipeline

23andMe is further streamlining its operations as it discontinues its pipeline of cancer-related therapeutic programs while it evaluates alternatives for its clinical and preclinical assets. The South San Francisco, Calif.-based human genetics company on ...

MarketWatch on MSN · 7h

23andMe to slash 40% of its workforce, end therapeutics program to cut costs

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as part of a restructuring effort to cut costs, the company said Monday.

23andMe cuts 40% of its workforce, discontinues all therapy programs

Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.

San Francisco Chronicle on MSN · 6h

23andMe to slash 40% of workforce as it restructures and shutters therapeutics division

Bay Area genetic testing company 23andMe announced Monday that it plans to lay off 40% of its workforce as part of a broader restructuring effort aimed at cutting costs and refocusing the company on its core business.

23andMe ends drug development and slashes staff

Me's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping ...

FierceBiotech10h

23andMe shutters cancer drug research programs, lays off 40% of staff

23andMe is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its ...

newsbytesapp.com1h

DNA-testing site 23andMe is slashing its workforce by 40%

23andMe, a leading name in the genetic testing business, has revealed plans to lay off some 200 employees, or nearly 40% of ...

The end of 23andMe’s drug discovery dream

23andMe, the genetics startup that has repeatedly captured the public imagination and then faced nearly fatal business ...

4h

23andMe to reduce overall headcount by 40% of workforce

Holding “announced a business restructuring to streamline operations and reduce costs. In addition, 23andMe is discontinuing ...

ENDPOINTS NEWS8h

23andMe to shut down its therapeutics division

Me is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company ...

16h

Federal law could prevent your 23andMe data deletion, but you should still try

Requesting deletion closes your account permanently and prevents your data from being used in further research (existing ...

8h

23andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the Future

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 millionDiscontinues development of therapeutics division and ...

Yahoo Finance4d

CORRECTION - 23andMe to Report Q2 FY2025 Financial Results

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- An earlier release under the same headline should have noted 23andMe ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results